Literature DB >> 30604635

Low-grade epithelial ovarian cancer: what a radiologist should know.

Sherif Elsherif1, Sanaz Javadi1, Chitra Viswanathan1, Silvana Faria1, Priya Bhosale1.   

Abstract

Ovarian cancer accounts for the death of over 100,000 females every year and is the most lethal gynecological malignancy. Low-grade serous ovarian carcinoma (LGSOC) and high-grade serous ovarian carcinoma (HGSOC) have been found to represent two distinct entities based on their molecular differences, clinical course, and response to chemotherapy. Currently, all ovarian cancers are staged according to the revised staging system of the International Federation of Gynecology and Obstetrics (FIGO). Imaging plays an integral role in the diagnosis, staging, and follow-up of ovarian cancers. This review will be based on the two-tier grading system of epithelial ovarian cancers, with the main emphasis on serous ovarian cancer, and the role of imaging to characterize low-grade vs high-grade tumors and monitor disease recurrence during follow-up.

Entities:  

Mesh：

Year:  2019        PMID： 30604635      PMCID： PMC6541194          DOI： 10.1259/bjr.20180571

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  62 in total

1.  Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group.

Authors:  C M Tempany; K H Zou; S G Silverman; D L Brown; A B Kurtz; B J McNeil
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Pathology and classification of ovarian tumors.

Authors:  Vivien W Chen; Bernardo Ruiz; Jeffrey L Killeen; Timothy R Coté; Xiao Cheng Wu; Catherine N Correa
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

3.  Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables.

Authors:  Ali Ayhan; Murat Gultekin; Cagatay Taskiran; Nilufer Yigit Celik; Alp Usubutun; Turkan Kucukali; Kunter Yuce
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

4.  Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings.

Authors:  A Rieber; K Nüssle; I Stöhr; D Grab; S Fenchel; R Kreienberg; S N Reske; H J Brambs
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

Review 5.  CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.

Authors:  Seung Eun Jung; Jae Mun Lee; Sung Eun Rha; Jae Young Byun; Jung Im Jung; Seong Tai Hahn
Journal:  Radiographics       Date:  2002 Nov-Dec       Impact factor: 5.333

6.  Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

Authors:  I Vergote; J De Brabanter; A Fyles; K Bertelsen; N Einhorn; P Sevelda; M E Gore; J Kaern; H Verrelst; K Sjövall; D Timmerman; J Vandewalle; M Van Gramberen; C G Tropé
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

7.  Grading ovarian serous carcinoma using a two-tier system.

Authors:  Anais Malpica; Michael T Deavers; Karen Lu; Diane C Bodurka; Edward N Atkinson; David M Gershenson; Elvio G Silva
Journal:  Am J Surg Pathol       Date:  2004-04       Impact factor: 6.394

Review 8.  From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation.

Authors:  Paula J Woodward; Keyanoosh Hosseinzadeh; Jeff S Saenger
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

9.  Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.

Authors:  Paolo Cossu-Rocca; Shaobo Zhang; Lawrence M Roth; John N Eble; Wenxin Zheng; Fadi W Abdul Karim; Helen Michael; Robert E Emerson; Timothy D Jones; Eyas M Hattab; Liang Cheng
Journal:  Mod Pathol       Date:  2006-04       Impact factor: 7.842

10.  Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.

Authors:  Paolo Castellucci; Anna M Perrone; Maria Picchio; Tullio Ghi; Mohsen Farsad; Cristina Nanni; Cristina Messa; Maria C Meriggiola; Giuseppe Pelusi; Adil Al-Nahhas; Domenico Rubello; Ferruccio Fazio; Stefano Fanti
Journal:  Nucl Med Commun       Date:  2007-08       Impact factor: 1.690
View more
  5 in total

Review 1.  Current update on malignant epithelial ovarian tumors.

Authors:  Sherif B Elsherif; Priya R Bhosale; Chandana Lall; Christine O Menias; Malak Itani; Kristina A Butler; Dhakshinamoorthy Ganeshan
Journal:  Abdom Radiol (NY)       Date:  2021-06-05

Review 2.  Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research.

Authors:  Angiolo Gadducci; Stefania Cosio
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

3.  Recurrence characteristics and clinicopathological results of borderline ovarian tumors.

Authors:  Lina Niu; Huihui Tian; Yongjun Xu; Jieqiong Cao; Xu Zhang; Junli Zhang; Jiajia Hou; Weiqin Lv; Junxia Wang; Li Xin; XuFeng Dong; Tao Xu; Yuan Nan; Hua Wei; Xinting Chai; Na Li; Yan Ni; Yun Shang; Lizhen Zhang; Ye Zhao
Journal:  BMC Womens Health       Date:  2021-03-31       Impact factor: 2.809

4.  lncRNA SNHG15 Promotes Ovarian Cancer Progression through Regulated CDK6 via Sponging miR-370-3p.

Authors:  Yi Wang; Minghong Ding; Xiaoqing Yuan; Ruibao Jiao; Dagao Zhu; Wanzhong Huang; Wenxia Deng; Yulong Liu
Journal:  Biomed Res Int       Date:  2021-10-25       Impact factor: 3.411

Review 5.  Low-Grade Serous Carcinoma of the Ovary: The Current Status.

Authors:  Abdulaziz Babaier; Hanan Mal; Waleed Alselwi; Prafull Ghatage
Journal:  Diagnostics (Basel)       Date:  2022-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.